GAM
TAK icon

Groupama Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Groupama Asset Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-53,500
Closed -$204M – 500
2024
Q2 		$204M Buy
53,500
+23,500
+78% +$311K 2.77% 8
2024
Q1 		$423K Buy
+30,000
New +$436K 0.01% 398

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Groupama Asset Management's TAK Position: Q3 2024 in Review

Groupama Asset Management sold out of Takeda Pharmaceutical (TAK) in Q3 2024, closing a stake of 53,500 shares — an estimated $204M sold.

Groupama Asset Management first reported a position in TAK in Q1 2024 and held it in 2 quarters. The position peaked at $204M in Q2 2024. 299 funds tracked by Wall St. Rank hold TAK as of Q3 2024.

  • Groupama Asset Management reported no remaining Takeda Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Groupama Asset Management sold 53,500 Takeda Pharmaceutical shares in Q3 2024, an estimated $204M.
  • Groupama Asset Management first reported a position in Takeda Pharmaceutical in Q1 2024 and held it in 2 quarters.
  • Groupama Asset Management's Takeda Pharmaceutical position peaked at $204M in Q2 2024.
  • 299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2024.

Based on Groupama Asset Management's 13F filing for Q3 2024, filed 15 Nov 2024.